Obesity is correlated with increased colorectal cancer (CRC) risk, but few studies have investigated lifetime body mass index (BMI) metrics and CRC risk. In a cohort of 139 229 subjects in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, we analysed the effects of life-course BMI trajectories on CRC risk. At 13 years of follow-up, 2031 subjects developed CRC. Compared with subjects who were never overweight/obese, subjects who first exceeded the threshold of 25 kg m−2 at age 20 had a higher CRC risk (HR = 1.28, 95% confidence interval (CI) = 1.11–1.48). A body weight gain of ≥15 kg between 20 and 50 years of age (HR = 1.34, 95% CI = 1.18–1.52) and baseline (HR = 1.24, 95% CI = 1.08–1.43) was significantly associated with increased CRC risk. BMI trajectory analyses revealed that the CRC risk increased gradually over the three BMI trajectories (HR = 1.11–1.27, Ptrend = 0.005) compared with subjects who maintained a normal BMI. Being overweight/obese at the onset of adulthood and BMI trajectories over the lifespan that result in obesity lead to an increased CRC risk.
Colorectal cancer (CRC) contributes to the global burden of cancer incidence, and despite declining rates of CRC in some developed countries, CRC incidence remains high.1 As revealed by epidemiological evidence, excess body fat (i.e., being overweight/obese) is a potentially modifiable lifestyle factor related to CRC.2 There are several methods to evaluate excess body fat, such as the body mass index (BMI), waist circumference, and waist-to-hip ratio, among others, although BMI is traditionally and widely used as a measurement for easy operation in large epidemiological studies.3 Previous studies have revealed that individuals with a higher BMI tend to have a higher CRC risk,4,5 but the relationships among changes to BMI trajectory, cumulative BMI measures during adulthood, and CRC incidence have not been investigated.
In this study, we explored the association of CRC risk with age-specific BMI, average BMI, body weight changes, and life-course BMI trajectories in a large prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial).
Materials and methods
The PLCO study is a population-based cohort study that aims to evaluate the accuracy and reliability of screening methods for prostate, lung, colorectal, and ovarian cancer.6 This study was based on 70 541 subjects in the intervention arm and 68 688 in the control arm. The subjects completed a baseline questionnaire consisting of questions on demographic characteristics and CRC characteristics (Supplementary Materials). The usage of the CRC database in the PLCO study was authorised by the ethics committees of the data providers and Nanjing Medical University.
Ascertainment of CRC
At study entry, subjects were not diagnosed with CRC. CRC cases were ascertained by self-reported annual questionnaires and linkage to the National Death Index (for completeness) and were histologically confirmed via medical record reviews (Supplementary Materials).
Assessment of BMI
BMI was ascertained from self-reported questionnaires completed by the participants in the PLCO study.7 We divided the BMI values (kg m−2) at the three analysed age points into four categories according to the World Health Organization criteria: underweight (<18.5 kg m−2); normal (18.5 to 24.9 kg m−2, reference); overweight (25 to 29.9 kg m−2); and obese (>30 kg m−2). Weight changes during adulthood were classified as loss (≤−2 kg), stable (>−2 to <5 kg, reference), gain (≥5 to <15 kg), and notable gain (≥15 kg)8 (Supplementary Materials).
Hazard ratios (HRs) and 95% confidence intervals (CIs) for CRC risk were estimated using Cox proportional hazard regression models to evaluate the relationships of age-specific BMI, average BMI, and weight change with CRC risk. To identify subjects with similar patterns of BMI development through the ages of 20 and 50 years and baseline, BMI trajectories based on the latent class growth model were generated with PROC TRAJ (SAS Institute, Inc., Cary, NC, USA).9 As a result, four trajectory categories (stable normal BMI, normal BMI to overweight, normal BMI to obese, and overweight to obese) were ultimately obtained.10 All the P values were two-sided, and the results were considered significant at P < 0.05. The analyses were performed using SAS version 9.4 (SAS Institute, Inc.) (Supplementary Materials).
This study tracked a total of 139 229 subjects and included 2031 cases. The age at trial entry was 62.6 ± 5.3 years, and the BMIs at the ages of 20 and 50 years and at baseline were 22.1 ± 3.0, 25.9 ± 4.2, and 27.3 ± 4.7 kg m−2, respectively (Supplementary Table S1). In addition, BMI was not observed to interact with the arm, sex, race, and cigarette smoking status (P > 0.05).
Age-specific BMI, average BMI, weight change, and CRC risk
The age-specific BMI analyses suggested that being overweight and obese at various stages of adulthood was more strongly associated with CRC risk, and the lowest HRs were obtained for the baseline measurement, which could be due to an unfavourable metabolic profile (mean age at baseline = 64.3).11 Specifically, compared with subjects who were never overweight/obese, subjects who first exceeded the threshold of 25 kg m−2 at age 20 had a higher CRC risk (HR = 1.28, 95% CI = 1.11–1.48) (Supplementary Table S2). When modeled continuously, subjects whose average BMI across the three time periods were classified as overweight or obese had an increased CRC risk (HR = 1.22, 1.18, and 1.21 per 5 kg m−2 increase) compared with normal-BMI subjects (Supplementary Table S3). A body weight gain of ≥15 kg between 20 and 50 years of age (HR = 1.34, 95% CI = 1.18–1.52) and baseline (HR = 1.24, 95% CI = 1.08–1.43) conferred a significant increase in CRC risk. Adjusting for the initial weight did not significantly affect the results (Supplementary Table S4).
BMI trajectories and CRC risk
Age-specific BMI trajectories are illustrated in Fig. 1. Compared with subjects that had a normal BMI throughout their adult lifespan, the subjects who progressed from a normal BMI at the onset of adulthood to an obese BMI at baseline had an increased CRC risk (HR = 1.18, 95% CI = 1.03–1.35) (Supplementary Table S5). CRC risk showed a borderline increase in subjects who were overweight (HR = 1.27, 95% CI = 0.99–1.64) at the onset of adulthood and became obese at baseline. This result could be due to the limited sample size in the overweight and obese groups because the Ptrend (Ptrend = 0.005) is statistically significant.
Furthermore, stratified analyses by demographic characteristics (randomisation arm, sex, family history of CRC, and cigarette smoking status) showed little connection to BMI and CRC risk, and a subanalysis by CRC characteristics (location, stage, and grade) did not reveal significant associations between BMI and CRC risk (Supplementary Tables S6-S11).
The results obtained for age-specific BMI, average BMI, body weight change, and BMI trajectory indicate a significant positive relationship between increased BMI and CRC risk if the subjects became overweight/obese at the onset of adulthood. Prior studies performed a dose–response analysis at a single time point in adulthood to demonstrate that an elevated BMI increases CRC risk.12 However, the weight of a subject might change over his/her adult life, and weight as a dynamic variable might play a critical role in the onset and progression of CRC.13 Therefore, our study expanded on prior studies assessing the association of BMI metrics across the adult lifespan with CRC risk.
Based on the abovementioned study, a BMI trajectory analysis was performed in this study, and the findings revealed that subjects with a normal or overweight BMI at the onset of adulthood that became obese by baseline have a higher CRC risk, suggesting that being overweight before adulthood could have biological effects on growth or be caused by an increased duration of excess weight.14
To our knowledge, a cohort study reduces the probability of recall bias, and this study might be suitable for examining the association between different BMI metrics over a subject’s lifespan and CRC risk.1,7,10 These findings may help young adults reduce CRC risk by focusing on body weight loss. We relied on self-reported body weight and height, which potentially introduced misclassifications in our assessment of BMI and might have limited the ability to investigate the association in this study.15 Another limitation is that we lack data for other measures of excess body fat, which might provide greater insight into the connection between excess body fat and CRC risk. Additionally, underlying diseases or lifestyle characteristics may cause weight loss, which affects the association between BMI trajectory and CRC risk.
In summary, this study suggests that becoming overweight/obese in early adulthood might affect the incidence of CRC and that body weight gain over the adult lifespan is associated with a slightly elevated CRC risk. These findings offer a significant strategy to aid the primary prevention of CRC in subjects with a high BMI starting at early adulthood.
Siegel, R. L. et al. Colorectal cancer statistics, 2017. Ca. Cancer J. Clin. 67, 177–193 (2017).
Kyrgiou, M. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356, j477 (2017).
Hingorjo, M. R., Qureshi, M. A. & Mehdi, A. Neck circumference as a useful marker of obesity: a comparison with body mass index and waist circumference. J. Pak. Med. Assoc. 62, 36–40 (2012).
Matsuo, K. et al. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann. Oncol. 23, 479–490 (2012).
Laake, I. et al. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol. Biomark. Prev. 19, 1511–1522 (2010).
Gohagan, J. K., Prorok, P. C., Greenwald, P. & Kramer, B. S. The PLCO Cancer Screening Trial: background, goals, organization, operations, results. Rev. Recent Clin. Trials 10, 173–180 (2015).
Kelly, S. P. et al. Prediagnostic body mass index trajectories in relation to prostate cancer incidence and mortality in the PLCO Cancer Screening Trial. J. Natl. Cancer Inst. 109, 1–9 (2017). Epub 2017/04/05.
de Mutsert, R., Sun, Q., Willett, W. C., Hu, F. B. & van Dam, R. M. Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study. Am. J. Epidemiol. 179, 1353–1365 (2014).
Jones, B. L. & Nagin, D. S. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol. Methods Res. 35, 542–571 (2007).
Petrick, J. L. et al. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies. Br. J. Cancer 116, 951–959 (2017).
Aleksandrova, K. et al. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur. J. Cancer 49, 3526–3536 (2013).
Ning, Y., Wang, L. & Giovannucci, E. L. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes. Rev. 11, 19–30 (2010).
Jochem, C. & Leitzmann, M. Obesity and colorectal cancer. Recent Results Cancer Res. 208, 17–41 (2016).
Renehan, A. G., Roberts, D. L. & Dive, C. Obesity and cancer: pathophysiological and biological mechanisms. Arch. Physiol. Biochem. 114, 71–83 (2008).
Connor Gorber, S., Tremblay, M., Moher, D. & Gorber, B. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes. Rev. 8, 307–326 (2007).
The authors thank all the PLCO study staff for their efforts and dedication to the study and acknowledge all the participants whose contributions made this project possible. This study was supported by National Natural Science Foundation of China (81773516), Distinguished Young Scholars of Nanjing (JQX13005), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).
Z.Z. and M.W. conceived and designed the workflow. D.G., M.N., and H.C. contributed analysis tools. R.Z., M.D., B.Z., and J.X. carried out the analysis of the data. R.Z., M.D., B.Z., and D.G. wrote the paper. All authors reviewed the manuscript.
The authors declare no competing interests.
The study data for this analysis were approved by the ethics committees of the data providers and Nanjing Medical University.
Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
Availability of data and material: The original data used in this study are available from PLCO study (https://biometry.nci.nih.gov/cdas/plco/).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Zheng, R., Du, M., Zhang, B. et al. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort. Br J Cancer 119, 130–132 (2018). https://doi.org/10.1038/s41416-018-0121-y
JNCI: Journal of the National Cancer Institute (2021)
Latent Class Trajectory Modeling of Adult Body Mass Index and Risk of Obesity-Related Cancer: Findings from the Melbourne Collaborative Cohort Study
Cancer Epidemiology Biomarkers & Prevention (2021)
A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer
Environment International (2021)
Physical multimorbidity and cancer prevalence in the National Health and Nutrition Examination Survey
Public Health (2021)
Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease
European Journal of Internal Medicine (2021)